Vydané akcie spoločnosti Hancock Jaffe Laboratories Inc
Aká je hodnota metriky Vydané akcie spoločnosti Hancock Jaffe Laboratories Inc?
Hodnota metriky Vydané akcie spoločnosti Hancock Jaffe Laboratories Inc je 8.685M
Aká je definícia metriky Vydané akcie?
Vydané akcie (Shares outstanding) je počet všetkých akcií spoločnosti alebo finančných aktív, ktoré boli autorizované, vydané a kúpené investormi a sú nimi vlastnené.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Vydané akcie spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Hancock Jaffe Laboratories Inc
Čomu sa venuje spoločnosť Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Firmy s metrikou vydané akcie podobnou spoločnosti Hancock Jaffe Laboratories Inc
- Hodnota metriky Vydané akcie spoločnosti Logic Instrument S.A je 8.647M
- Hodnota metriky Vydané akcie spoločnosti Sportscene je 8.648M
- Hodnota metriky Vydané akcie spoločnosti Exicure Inc je 8.651M
- Hodnota metriky Vydané akcie spoločnosti Athenex Inc je 8.663M
- Hodnota metriky Vydané akcie spoločnosti First Internet Bancorp je 8.668M
- Hodnota metriky Vydané akcie spoločnosti Northern Lion Gold je 8.683M
- Hodnota metriky Vydané akcie spoločnosti Hancock Jaffe Laboratories Inc je 8.685M
- Hodnota metriky Vydané akcie spoločnosti Wereldhave Belgium SCA je 8.692M
- Hodnota metriky Vydané akcie spoločnosti Gravitas One Capital je 8.700M
- Hodnota metriky Vydané akcie spoločnosti OFS Credit je 8.700M
- Hodnota metriky Vydané akcie spoločnosti CoreCard je 8.701M
- Hodnota metriky Vydané akcie spoločnosti MoSys je 8.705M
- Hodnota metriky Vydané akcie spoločnosti Kura Sushi USA je 8.711M